Invicorp

Phentolamine mesilate and Aviptadil, the active ingredients in Invicorp, are an alpha‑adrenergic antagonist and a vasoactive intestinal peptide analog presented as an injectable formulation for intracavernous use. By inducing vasodilation of penile arteries and relaxing smooth muscle, they increase intracavernous blood flow to treat erectile dysfunction in adult males.

GNH USA supplies Invicorp as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Invicorp acts on the penile vascular system to improve erectile function.

Erectile dysfunction (general): facilitates erection by increasing blood flow to the penis. Penile arterial insufficiency: improves penile blood flow to support erection. Post‑prostatectomy erectile dysfunction: aids recovery of erectile function after surgery.

Common and serious adverse reactions have been reported with intracavernous administration of Invicorp.

Common Side Effects: - Pain at the injection site - Bruising or hematoma - Priapism (prolonged erection) - Headache

Serious or Rare Side Effects: - Severe hypotension - Allergic reaction (anaphylaxis)

Precautions should be observed to minimize risks associated with intracavernous use of Invicorp.

Contraindication: avoid use in patients with known hypersensitivity to either component. Cardiovascular risk: assess for severe coronary artery disease before administration. Coagulation disorders: use with caution in patients with bleeding tendencies. Concurrent use of nitrates or other vasodilators: may cause excessive hypotension. Priapism history: monitor closely for prolonged erections. Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Invicorp may interact with other agents that affect vascular tone or blood pressure.

Major Interactions (Avoid): - Nitrates (e.g., nitroglycerin): combined vasodilation can cause severe hypotension. - Alpha‑blockers (e.g., prazosin): additive blood pressure lowering effect. - PDE5 inhibitors (e.g., sildenafil) when used simultaneously: risk of prolonged erection.

Moderate Interactions (Monitor Closely): - Antihypertensives (e.g., beta‑blockers): may require dose adjustment. - Anticoagulants (e.g., warfarin): increased risk of bleeding at injection site. - Selective serotonin reuptake inhibitors (SSRIs): may affect sexual response.